RMAM
ROSG

Raab & Moskowitz Asset Management’s Rosetta Genomics Ltd. ROSG Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-17
Closed – – 453
2014
Q4 		$0 Buy
+17
New +$552 ﹤0.01% 499

Other funds holding ROSG

HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raab & Moskowitz Asset Management's ROSG Position: Q1 2015 in Review

Raab & Moskowitz Asset Management sold out of Rosetta Genomics Ltd. (ROSG) in Q1 2015, closing a stake of 17 shares.

Raab & Moskowitz Asset Management first reported a position in ROSG in Q4 2014 and held it in 1 quarter. The position peaked at $0 in Q4 2014. 12 funds tracked by Wall St. Rank hold ROSG as of Q1 2015.

  • Raab & Moskowitz Asset Management reported no remaining Rosetta Genomics Ltd. position as of Q1 2015 after selling out during the quarter.
  • Raab & Moskowitz Asset Management sold 17 Rosetta Genomics Ltd. shares in Q1 2015.
  • Raab & Moskowitz Asset Management first reported a position in Rosetta Genomics Ltd. in Q4 2014 and held it in 1 quarter.
  • Raab & Moskowitz Asset Management's Rosetta Genomics Ltd. position peaked at $0 in Q4 2014.
  • 12 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q1 2015.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2015, filed 12 May 2015.